August 2016 – In this Issue

Education | Society | Forward Fund | Science & Research
Membership | Publications

A Message from the President

Dear Colleagues,

The Society for Immunotherapy of Cancer (SITC) 2016 election is rapidly approaching and your opinion is vitally important in helping determine the future direction of the society. All Regular members current in their dues and Emeritus members will have the opportunity to vote for three (3) At-Large Directors and the next Vice President who will transition to President in 2018.

The election opens on Thursday, September 8 and runs through September 22 at 5:00 p.m. EST. In order for the election results to be valid, a 20% quorum of eligible voters must be reached. Your participation in the election process is critical to maintaining a healthy and dynamic professional society that truly represents the core values and ideals of our membership. I am delighted to introduce the candidates here. Please review these accomplished individuals and exercise your right to vote!

Election results will be reported at the SITC Annual Meeting in November. I am pleased to report that we have already received a record-breaking 492 regular and applications for late-breaking abstract submissions. This year promises to be another one with cutting-edge science and an increasing number of clinical trial results being reported at our highly acclaimed SITC Annual Meeting & Associated Programs on November 9-13, 2016 at the Gaylord National Hotel & Convention Center in National Harbor, Maryland. Register today for the world’s leading destination for scientific exchange, networking and education in the cancer immunotherapy field.

I want to thank you for your continued commitment to the field and I look forward to seeing you in November at SITC 2016.

Best Regards,

Howard L. Kaufman, MD, FACS
SITC President

Education

Non-Small Cell Lung Cancer Immunotherapy: Advancing Hope^TM

Designed to comprehensively educate patients, physicians and registered nurses in immunotherapy as a treatment option for non-small cell lung cancer, SITC has partnered with leading lung cancer experts and patient advocacy groups to create a short, patient-friendly video and companion CME- and CNE-certified activity entitled, Non-Small Cell Lung Cancer Immunotherapy: Advancing Hope^TM.

SITC's 31^st Annual Meeting & Associated Programs
The world's leading cancer immunotherapy meeting

Gaylord National Hotel & Convention Center
National Harbor, Maryland | November 9-13, 2016

Join us at SITC 2016!
Register now for our highly-anticipated 31^st Annual Meeting & Associated Programs:

• New Cancer Immunotherapy Agents in Development
• Primer on Tumor Immunology and Cancer Immunotherapy™
• Meet-the-Expert Lunch for Early Career Scientists
• Workshop on Challenges, Insights, and Future Directions for Mouse and Humanized Models in
    Cancer Immunology and Immunotherapy
• Value of Cancer Immunotherapy Summit

New this Year! Receive Multi-Program Discount
Register for the 31^st Annual Meeting and save 10% on your registration for one of the following programs: New Cancer Immunotherapy Agents in Development, Workshop or Primer. Although you may register for each of the programs listed, discount is limited to one program and is not applicable with the Annual Meeting one-day only rate.

Book Your Hotel Room Now
Space is filling up quickly!

Reserve Your Exhibit Booth and Ancillary Event Space
Book your booth today or host an event at SITC 2016.

Support SITC 2016
Increase awareness about your company and educate meeting attendees on your products and services by engaging in the wide array of support opportunities SITC offers to its corporate partners.

Cancer Immunotherapy 101

Over 3,000 oncologists, registered nurses, pharmacists and healthcare team members have completed SITC’s Cancer Immunotherapy (CIT) 101 program in the last three years! Help us educate more practitioners about the effective use of immunotherapy by sharing this integral program with colleagues.

Boston, Massachusetts – Thursday, September 8, 2016
Baltimore, Maryland – Friday, September 30, 2016
Portland, Oregon – Thursday, October 13, 2016
Charlottesville, Virginia – Friday, October 14, 2016

Cancer Immunotherapy 101 Online Series

Can’t make it to a CIT 101 program or looking to refresh what you have already learned? SITC is pleased to offer an accompanying series of online CME-, CNE- and CPE-certified activities to access at your convenience.

Learn the building blocks of cancer immunotherapy and check out the best of CIT 101 today with the premier activity Immunology and Immunotherapy 101 for the Non-Immunologist with Christian Capitini, MD.

SITC's Collaborative Programs
Where else will SITC be? Check out our upcoming collaborative programs:

Budapest, Hungary – Friday, September 9-11, 2016
Give Life a Chance Through Immunotherapy
Patient education presented by the National Institute of Oncology and the Hungarian League Against Cancer

Xiamen, Fujian, China – Saturday, September 24, 2016
The Sixth CSCO-CAHON-SITC Joint Symposium on Immuno-Oncology
A joint workshop at the Chinese Society of Clinical Oncology (CSCO) 2016 Annual Meeting

Boston, Massachusetts – Tuesday, September 27, 2016
Radiation as Adjuvant to Immunotherapy: Optimizing Regimens and Sites
A joint session at the American Society for Radiation Oncology (ASTRO) 2016 Annual Meeting

Society

Wanted: Bass Player to Join The Checkpoints Band

Calling all bass players who can play music styles ranging from the blues to rock. The selected individual would be expected to learn a set list of around 40 cover songs. Candidates must be able to attend the SITC and ASCO Annual Meetings, as well as occasional additional performance and rehearsal times. Fun personality required. Interested parties please contact:

Thomas F. Gajewski, MD, PhD
University of Chicago
tgajewsk@medicine.bsd.uchicago.edu

See what we are all about.

Forward Fund

Apply for the SITC-Bristol-Myers Squibb Cancer Immunotherapy
Translational Fellowship

Submission Period: July 18 — August 29, 2016
This two-year, $200,000 award aims to provide dedicated funding for an individual who has an MD or combined MD/PhD and a vested interest in furthering the research and translation of cancer immunotherapy. Apply today.

                      

Science & Research

FDA Approves Pembrolizumab for Head and Neck Cancer

On August 5, 2016, pembrolizumab was granted accelerated approval by the U.S. Food and Drug Administration for patients with recurrent or metastatic head and neck squamous cell carcinoma with disease progression on or after platinum-containing chemotherapy.

Read the full U.S. FDA news release here.

Membership

Cast Your Vote in the Upcoming SITC Election

All Regular members and Emeritus members are urged to cast their ballots September 8-22 for:

• Vice President
• Three At-Large Directors

Meet the Candidates
Biographies and election platform statements from all of our candidates are available now.

Renew Your Dues and Vote
To participate in SITC's upcoming election, Regular and Emeritus members can renew their membership dues online now.

Join SITC or Renew Your Membership Today

There is still time to enjoy these exciting member benefits!

• Save up to $400 on SITC 2016 registration
• Free article submission to JITC ($2,500 value)
• Free access to slide decks from archived live SITC events
• Voting privileges for the upcoming SITC election (Regular and Emeritus members)
• Eligibility for Fellowship and Young Investigator Awards (accepting applications now)

Do You Love Being Part of SITC? Connect-a-Colleague

Use our online tool to send a personalized invitation to your colleagues. All you need is a name and email address.

Check out our leaderboard.

Publications

JITC – The Resource for Cutting-Edge Science in the Field

Publish in the Journal for ImmunoTherapy of Cancer (JITC), SITC's official open access, peer-reviewed journal. SITC members receive waived article processing charges for papers accepted through 2016.

Read the articles in the August issue.

ADVERTISEMENT

Society for Immunotherapy of Cancer (SITC)
555 East Wells Street, Suite 1100 | Milwaukee, Wisconsin 53202-3823 USA
Phone: +1 414 271 2456 | Email: info@sitcancer.org

© 2016 Society for Immunotherapy of Cancer

Join us on:

       

If you do not wish to be included in our mailing list, please forward this message to info@sitcancer.org with the word "Remove" in the subject line.

Please add info@sitcancer.org to your safe senders list.